Holen Sie sich die Stockscreener-App
8.45
3.30%
0.27
Handel nachbörslich:
8.87
0.42
+4.97%
Schlusskurs vom Vortag:
$8.18
Offen:
$8.17
24-Stunden-Volumen:
142.64K
Relative Volume:
0.29
Marktkapitalisierung:
$154.02M
Einnahmen:
$62.81M
Nettoeinkommen (Verlust:
$-13.75M
KGV:
-10.56
EPS:
-0.8
Netto-Cashflow:
$153.00K
1W Leistung:
+3.55%
1M Leistung:
+2.18%
6M Leistung:
+28.03%
1J Leistung:
-11.33%
1-Tages-Spanne:
$8.14
$8.58
1-Wochen-Bereich:
$7.755
$8.58
52-Wochen-Spanne:
$3.78
$14.13
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Vergleichen Sie OPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
8.45 | 154.02M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
215.95 | 36.39B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
53.21 | 9.87B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
40.45 | 7.46B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
84.52 | 7.21B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.45 | 6.30B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - The Manila Times
OptimizeRx Co. (NASDAQ:OPRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Shares Purchased by Kennedy Capital Management LLC - MarketBeat
Whetstone Capital Advisors LLC Invests $6.56 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Blair William & Co. IL Reduces Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Short Interest in OptimizeRx Co. (NASDAQ:OPRX) Grows By 22.0% - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Sees Significant Increase in Short Interest - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance
Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com
OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener
OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat
Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register
OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx Corp SEC 10-K Report - TradingView
What is B. Riley's Estimate for OptimizeRx Q1 Earnings? - MarketBeat
OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa
OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World
Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - MSN
Roth Capital Predicts OptimizeRx's Q1 Earnings (NASDAQ:OPRX) - MarketBeat
Research Analysts Issue Forecasts for OptimizeRx Q1 Earnings - Defense World
OptimizeRx (NASDAQ:OPRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Upgraded at B. Riley - MarketBeat
OptimizeRx Corp [OPRX] CEO makes an insider purchase of 20,000 shares worth 0.1 million. - Knox Daily
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript - Insider Monkey
OptimizeRx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion - Investing.com Canada
OptimizeRx Q4 results ‘at odds with muted’ outlook, says Roth MKM - TipRanks
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges By Investing.com - Investing.com South Africa
OPTIMIZERx earnings beat by $0.04, revenue topped estimates - Investing.com
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges - Investing.com UK
OptimizeRx Corp reports results for the quarter ended December 31Earnings Summary - TradingView
OptimizeRx Corporation Provides Earnings Guidance for the Full Year 2025 -March 12, 2025 at 07:30 am EDT - MarketScreener
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results - TradingView
OPTIMIZERX Earnings Results: $OPRX Reports Quarterly Earnings - Quiver Quantitative
ForexTV | Small Business Resources - ForexTV.com
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):